WHO ICTRP trial
The therapeutic effect of inhaled budesonide in patients with unexplained…
IRCT2013031212419N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT2013031212419N2 |
|---|---|
| Public title | The therapeutic effect of inhaled budesonide in patients with unexplained chronic cough. |
| Scientific title | Clinical trial of recovery rate comparison in patients with unexplained chronic cough in the two groups receiving oral cetirizine with and without inhaled budesonide. |
| Primary sponsor | The budget will be funded by researchers. |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | unexplained chronic cough. Cough |
| Interventions | Intervention 1: Intervention group or Intervene 1: Treatment will be done by cetirizine (letizen®) 10 milligram oral daily plus inhale budesonide Turbuhaler 200 microgram 2 puff every 12 hours for 25 days. Intervention 2: Control group or… |
| Registration date | Nov 19, 2017 |
| Target size | 68 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: